Vera Therapeutics, Inc.
NASDAQ: VERA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Gary Barrera
- Employees
- 152
- Headquarters
- Brisbane, United States
- IPO year
- 2021
- Market cap
- $2.8B
- Website
- https://veratx.com
Loading VERA…
Loading profile data…Frequently asked questions about VERA
What does Vera Therapeutics, Inc. (VERA) do?
Vera Therapeutics, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of treatments for significant immunological disorders, primarily within the United States. Their leading therapeutic candidate is atacicept, a fusion protein that patients self-administer as a subcutaneous injection. This drug is cu...
Where does VERA trade?
Vera Therapeutics, Inc. (VERA) trades on the NASDAQ Global Market.
What sector is VERA in?
Vera Therapeutics, Inc. (VERA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Vera Therapeutics, Inc.?
Gary Barrera is the chief executive officer of Vera Therapeutics, Inc. (VERA).
Where is Vera Therapeutics, Inc. headquartered?
Vera Therapeutics, Inc. is headquartered in United States.
Does VERA pay a dividend?
Vera Therapeutics, Inc. (VERA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VERA go public?
Vera Therapeutics, Inc. (VERA) completed its initial public offering in 2021.